Literature DB >> 30561236

Measuring the quality of dying and death in advanced cancer: Item characteristics and factor structure of the Quality of Dying and Death Questionnaire.

Kenneth Mah1, Sarah Hales1,2, Isuri Weerakkody1, Lucy Liu1, Samantha Fernandes1, Anne Rydall1, Sigrun Vehling3,4, Camilla Zimmermann1,2,5,6,7, Gary Rodin1,2,6,7.   

Abstract

Entities:  

Keywords:  Quality of dying and death; advanced cancer; end-of-life care; factor analysis; palliative care; questionnaires

Mesh：

Year:  2018        PMID： 30561236     DOI： 10.1177/0269216318819607

Source DB:  PubMed          Journal:  Palliat Med        ISSN： 0269-2163            Impact factor:   4.762


× No keyword cloud information.
  4 in total

1.  Evaluation of the Quality of Dying and Death Questionnaire in Kenya.

Authors:  Kenneth Mah; Richard A Powell; Carmine Malfitano; Nancy Gikaara; Lesley Chalklin; Sarah Hales; Anne Rydall; Camilla Zimmermann; Faith N Mwangi-Powell; Gary Rodin
Journal:  J Glob Oncol       Date:  2019-06

2.  Translation, Cultural, and Age-Related Adaptation and Psychometric Properties of Persian Version of "Quality of Dying and Death" in Nurses Working in Neonatal Intensive Care Units.

Authors:  Mahsa Moslemi; Lida Nikfarid; Manijeh Nourian; Maliheh Nasiri; Ferershteh Rezayi
Journal:  Indian J Palliat Care       Date:  2020-01-28

3.  Existential distress in patients with advanced cancer and their caregivers: study protocol of a longitudinal cohort study.

Authors:  Rebecca Philipp; Anna Kalender; Martin Härter; Carsten Bokemeyer; Karin Oechsle; Uwe Koch; Sigrun Vehling
Journal:  BMJ Open       Date:  2021-04-24       Impact factor: 2.692

4.  Protocol for the development and multisite validation of the Quality of Dying and Death-Revised Global Version scale.

Authors:  Ekaterina An; Alyssa Tilly; Kenneth Mah; Warren Lewin; Mano Chandrakumar; Arnell Baguio; Nazira Jaffer; Maria Chikasema; Lameck Thambo; Christian Ntizimira; Eve Namisango; Sarah Hales; Camilla Zimmermann; Kayla Wolofsky; Mary Goombs; Gary Rodin
Journal:  BMJ Open       Date:  2022-07-25       Impact factor: 3.006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.